277 related articles for article (PubMed ID: 31171738)
21. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
22. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
23. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
24. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
25. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
26. Recent Advances in Targeted Drug Delivery Approaches Using Lipidic and Polymeric Nanocarriers for the Management of Alzheimer's Disease.
Jain D; Rashid MA; Ahmad FJ
Curr Pharm Des; 2021; 27(43):4388-4403. PubMed ID: 34579627
[TBL] [Abstract][Full Text] [Related]
27. Lipid-Based Nanocarriers in the Treatment of Glioblastoma Multiforme (GBM): Challenges and Opportunities.
Gupta T; Sahoo RK; Singh H; Katke S; Chaurasiya A; Gupta U
AAPS PharmSciTech; 2023 Apr; 24(4):102. PubMed ID: 37041350
[TBL] [Abstract][Full Text] [Related]
28. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
Garg T; Bhandari S; Rath G; Goyal AK
J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
[TBL] [Abstract][Full Text] [Related]
29. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
30. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
31. Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery.
Xing R; Mustapha O; Ali T; Rehman M; Zaidi SS; Baseer A; Batool S; Mukhtiar M; Shafique S; Malik M; Sohail S; Ali Z; Zahid F; Zeb A; Shah F; Yousaf A; Din F
Biomed Res Int; 2021; 2021():9968602. PubMed ID: 34285920
[TBL] [Abstract][Full Text] [Related]
32. Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management.
Kataria I; Shende P
Chem Phys Lipids; 2022 Mar; 243():105177. PubMed ID: 35122739
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
[TBL] [Abstract][Full Text] [Related]
34. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
35. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
36. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho HJ; Park JW; Yoon IS; Kim DD
Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting.
Jain SK; Chaurasiya A; Gupta Y; Jain A; Dagur P; Joshi B; Katoch VM
J Microencapsul; 2008 Aug; 25(5):289-97. PubMed ID: 18608808
[TBL] [Abstract][Full Text] [Related]
38. Recent expansions of novel strategies towards the drug targeting into the brain.
Alexander A; Agrawal M; Uddin A; Siddique S; Shehata AM; Shaker MA; Ata Ur Rahman S; Abdul MIM; Shaker MA
Int J Nanomedicine; 2019; 14():5895-5909. PubMed ID: 31440051
[TBL] [Abstract][Full Text] [Related]
39. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
Madkhali OA
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
[TBL] [Abstract][Full Text] [Related]
40. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]